Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acquired Immunodeficiency Syndrome (AIDS)”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00242840
What this trial is testing

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 20
Not applicableLooking for participantsNCT05910268
What this trial is testing

Peru Decentralized HIV Care

Who this might be right for
HIV
Yale University 1,450
Early research (Phase 1)Study completedNCT01056874
What this trial is testing

Effect Of Maraviroc On The Pharmacokinetics Of Digoxin

Who this might be right for
HealthyHIV Infections
ViiV Healthcare 12
Not applicableStudy completedNCT00002103
What this trial is testing

A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
U.S. Bioscience
Testing effectiveness (Phase 2)Ended earlyNCT00333424
What this trial is testing

Thai Prophylactic HIV Vaccine Phase I Study

Who this might be right for
HIV
Kirby Institute 8
Not applicableStudy completedNCT01929759
What this trial is testing

Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen

Who this might be right for
HIV Disease
Massachusetts General Hospital 10
Large-scale testing (Phase 3)UnknownNCT00199979
What this trial is testing

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

Who this might be right for
Hiv Infection With Antiretroviral Therapy IndicationCD4 Below 350/µL or Below 15%
MEDEX 250
Testing effectiveness (Phase 2)Study completedNCT00484627
What this trial is testing

Effects of Creatine and Resistance Exercise Training in People With HIV Infection

Who this might be right for
HIV Infections
National Center for Complementary and Integrative Health (NCCIH) 43
Not applicableStudy completedNCT00005227
What this trial is testing

AIDS-Associated Cardiomyopathy

Who this might be right for
Acquired Immunodeficiency SyndromeHeart DiseasesMyocardial Diseases+1 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT02744261
What this trial is testing

Developing Rectal USPE Measures for Suppositories (Project DRUM-S)

Who this might be right for
Microbicide Delivery System Perceptibility and Acceptability
The Miriam Hospital 32
Testing effectiveness (Phase 2)Study completedNCT02588586
What this trial is testing

The Safety and Antiretroviral Activity of 3BNC117

Who this might be right for
HIV-1 Infection
Rockefeller University 17
Not applicableUnknownNCT03878186
What this trial is testing

Efficacy Of A Cognitive Behavioral Therapy To Decrease Threat Appraisal In HIV Participants Initiating Antiretroviral

Who this might be right for
HIVThreat Appraisal
National Institute of Medical Sciences and Nutrition, Salvador Zubiran 50
Not applicableStudy completedNCT04853394
What this trial is testing

Tajik Migrant Health Education Study

Who this might be right for
HIV InfectionsHepatitis CRisky Health Behavior+1 more
University of Illinois at Chicago 420
Not applicableStudy completedNCT02426866
What this trial is testing

Risk of CV Events With EFV vs. EFV-free Regimens

Who this might be right for
HIV/AIDS
Bristol-Myers Squibb 29,612
Early research (Phase 1)Study completedNCT00000810
What this trial is testing

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Large-scale testing (Phase 3)Study completedNCT02489461
What this trial is testing

Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy

Who this might be right for
HIV-1-infection
Viriom 150
Testing effectiveness (Phase 2)UnknownNCT00003942
What this trial is testing

Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Systemix 15
Post-approval studies (Phase 4)Study completedNCT01925183
What this trial is testing

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

Who this might be right for
Hepatitis C, ChronicHIV
Markus Peck-Radosavljevic 6
Large-scale testing (Phase 3)Study completedNCT00301561
What this trial is testing

Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL)

Who this might be right for
HIV InfectionsAIDS
French National Agency for Research on AIDS and Viral Hepatitis 459
Not applicableStudy completedNCT00661960
What this trial is testing

Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir Therapy

Who this might be right for
HIV InfectionsAIDS
University of California, Davis 25
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation